Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Miao

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Pathogenesis, pathological characteristics and individualized therapy for immune-related adverse effectsKang Miao, Li Zhang
Cancer Pathogenesis and Therapy|February 8, 2024
Incidence rate and treatment strategy of immune checkpoint inhibitor mediated hepatotoxicity: A systematic reviewKang Miao, Li Zhang
Interdisciplinary Sciences, Computational Life Sciences|June 21, 2021
Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic ReviewKang Miao, Li Zhang
Cancer Innovation|December 13, 2023
Pyrotinib-associated acute kidney injury: A case reportKang Miao, Li Zhang, Xiaoyan Si
American Journal of Translational Research|May 2, 2020
Update on the role of endoplasmic reticulum stress in asthmaKang Miao, Lei Zhang, Ting Pan, et al.
American Journal of Translational Research|June 9, 2020
A crucial role of endoplasmic reticulum stress in cellular responses during pulmonary arterial hypertensionTing Pan, Lei Zhang, Kang Miao, et al.
Thoracic Cancer|February 12, 2022
Second primary tumor after immune checkpoint inhibitor therapy: A case reportKang Miao, Shuangni Yu, Jun Ni, et al.
Thoracic Cancer|March 21, 2023
Savolitinib versus crizotinib for treating MET positive non-small cell lung cancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Chinese Medical Journal|July 12, 2021
Stem cell therapy for chronic obstructive pulmonary diseaseYun-Tian Chen, Kang Miao, Linfu Zhou, et al.
Huan Jing Ke Xue= Huanjing Kexue|September 11, 2023
[Pathway and Policy for China's Provincial Carbon Emission Peak]An-Kang Miao, Yue Yuan, Han Wu, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Pathogenesis, pathological characteristics and individualized therapy for immune-related adverse effectsKang Miao, Li Zhang
Cancer Pathogenesis and Therapy|February 8, 2024
Incidence rate and treatment strategy of immune checkpoint inhibitor mediated hepatotoxicity: A systematic reviewKang Miao, Li Zhang
Interdisciplinary Sciences, Computational Life Sciences|June 21, 2021
Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic ReviewKang Miao, Li Zhang
Cancer Innovation|December 13, 2023
Pyrotinib-associated acute kidney injury: A case reportKang Miao, Li Zhang, Xiaoyan Si
American Journal of Translational Research|May 2, 2020
Update on the role of endoplasmic reticulum stress in asthmaKang Miao, Lei Zhang, Ting Pan, et al.
American Journal of Translational Research|June 9, 2020
A crucial role of endoplasmic reticulum stress in cellular responses during pulmonary arterial hypertensionTing Pan, Lei Zhang, Kang Miao, et al.
Thoracic Cancer|February 12, 2022
Second primary tumor after immune checkpoint inhibitor therapy: A case reportKang Miao, Shuangni Yu, Jun Ni, et al.
Thoracic Cancer|March 21, 2023
Savolitinib versus crizotinib for treating MET positive non-small cell lung cancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Chinese Medical Journal|July 12, 2021
Stem cell therapy for chronic obstructive pulmonary diseaseYun-Tian Chen, Kang Miao, Linfu Zhou, et al.
Huan Jing Ke Xue= Huanjing Kexue|September 11, 2023
[Pathway and Policy for China's Provincial Carbon Emission Peak]An-Kang Miao, Yue Yuan, Han Wu, et al.
Pageof 3